/
RSS Feed
Steven Nissen, Cleveland Clinic, Cleveland, Ohio
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
Among patients whose atheroma had been measured by a catheter ultrasound probe, the use of treatment with rosuvastatin at sufficiently higher doses to cause a large reduction of LDL cholesterol levels caused atheroma to regress. Audio Medica’s Peter Goodwin heard from Steven Nissen of the Cleveland Clinic who announced his group’s results from the ASTEROID study at the American College of Cardiology meeting in Atlanta.
[audio:https://www.audiomedica.com/podcasting/acc2006/steven_nissen.mp3]
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
Among patients whose atheroma had been measured by a catheter ultrasound probe, the use of treatment with rosuvastatin at sufficiently higher doses to cause a large reduction of LDL cholesterol levels caused atheroma to regress. Audio Medica’s Peter Goodwin heard from Steven Nissen of the Cleveland Clinic who announced his group’s results from the ASTEROID study at the American College of Cardiology meeting in Atlanta.
